Screening brain MRI study for stage IV breast cancer
Part of Cancer, Skin clinical trials.
This trial checks whether taking screening brain MRI scans in people with stage IV breast cancer helps find brain involvement earlier. It may help guide treatment decisions for those who would otherwise only get brain imaging after symptoms start.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have confirmed breast cancer, and your ER, PR, and HER2 test results are documented
- Your breast cancer is stage IV outside the brain and has either progressed after first treatment (for HR+/HER2−) or has specific features (for TN or HER2+)
- You are expected to live at least 6 months, and your daily functioning is good (ECOG 0 to 2)
- You can understand the study and agree to follow all visit and scan requirements
- You have never had brain metastases or leptomeningeal disease, and you do not have medical reasons that require a brain MRI for other causes right now
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks the brain using MRI in people with breast cancer that has spread outside the breast or can’t be fully removed. The goal is to screen for brain involvement and see how MRI findings fit with treatment timing, when it’s safe to do so.
This trial is testing a new way to use MRI scans to find breast cancer that has spread to other parts of the body early. It is for people who have had aggressive breast cancer (HER2 positive or triple negative) and finished treatment with surgery, but still have a higher risk of the cancer coming back.
This trial tests whether regular brain MRI scans can help detect brain metastases early in patients with stage IV breast cancer who do not yet have any known brain metastases. The goal is to see if early detection improves outcomes.
This trial uses an MRI scan to look for early signs of breast cancer spreading to the brain in people with certain aggressive breast cancer types (triple-negative or HER2-positive) that are stage IIb or III. The goal is to find and treat brain metastases earlier, before they cause symptoms.
This trial looks at whether doing an MRI scan of the brain for people with stage IV lung cancer helps in their care. The goal is to find brain issues early (if present) so treatment decisions can be made sooner.
This trial uses regular MRI scans to screen for brain metastases in people with certain advanced cancers (HER2-positive or triple-negative breast cancer, non-small cell lung cancer, or melanoma). The goal is to detect brain spread early, which may help guide treatment and improve outcomes.
Hear when a new Triple Negative Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.